Distribution of Peripheral Blood Mononuclear Cell Subtypes in Patients with West Syndrome: Impact of Synacthen Treatment

CONCLUSIONS: Our findings lend further support for the involvement of inflammation-related mechanisms in WS. New-onset WS patients are inclined to display increased plasma cells in the peripheral blood. Synacthen treatment does not show a beneficial effect on most effector acquired and innate immunity subsets.PMID:37459957 | DOI:10.1016/j.imlet.2023.07.007

Source: Immunology Letters - July 17, 2023 Category: Allergy & Immunology Authors: Selen Soylu Minara Cherkezzade Ece Akbay ır Hande Y üceer Korkmaz Gizem Koral Elif Şanlı P ınar Topaloğlu Vuslat Y ılmaz Erdem T üzün Cem İsmail Küçükali Source Type: research